BEAMSTART Logo

HomeCompaniesProfile

Kindly

Home diagnostic & subscription program for people with sperm and ovary 


Company Size

11 - 50 employees

Year Founded

2021


About Kindly

Kindly is building at-home diagnostic and treatment plans to service 130 Million infertile Indians, starting with at-home semen diagnostic.
We launched 4 months ago, we already have ~$8000 of monthly revenue, and we’re growing 50% every month.
On average we make $60 per customer, this is an 8 Billion USD market opportunity.

Financials Beta

Business Model: Not Specified

Revenues: Not Specified

Expenses: Not Specified

Debt: Request

Operating Status: Active

Funding Raised: $0

Investment Rounds: 0 Rounds

Funding Stage: Not Specified

Last Funding Date: Not Specified


Frequently Asked Questions

What industry is Kindly in?

Kindly is in the Biotech, Healthcare, and Software as a Service (SaaS) industry.

How long has Kindly been in business?

Kindly was established in 2021 (4 years in business).

Is Kindly currently hiring?

No, Kindly is currently not hiring.

Visit Kindly's Jobs Page to stay updated with any upcoming open positions.

Which country is Kindly headquartered in?

Kindly is based in India.

Share This Profile

More Companies

JetPack Aviation

Flying motorcycles

Deel

The all-in-one HR and payroll platform for global teams

authzed

Open Source, Google Zanzibar-inspired permissions database

bloop

Modernising legacy code with AI

Able Jobs

India's Largest Placement Platform for Early Professionals

Nabla Bio

We use AI to design antibodies for intractable diseases

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.